← Leaderboards
Arthur A. Vandenbark
Portland Va Medical Center
$10,836,294
Attributed
$12,332,105
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $998.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,332,105 · 7
VA$0 · 3
By mechanism
R01$6,845,686 · 2
R44$2,991,622 · 1
R42$2,170,193 · 2
R41$324,604 · 2
I01$0 · 2
IK6$0 · 1
Top collaborators
- Jeffrey S King2 shared
- Renee Lynn Shirley1 shared
Others in their field
Top investigators on “Multiple Sclerosis”
- David A. Hafler · Brigham And Women'S Hospital$33,720,341
- Vijay K Kuchroo · Brigham And Women'S Hospital$32,935,587
- Stephen L Hauser · University Of California San Francisco$32,469,388
- Katerina Akassoglou · University Of California San Diego$24,525,425
- Abdolmohamad Rostami · Thomas Jefferson University$23,969,638
- Stephen D Miller · Northwestern University$23,969,272
Research focus
Multiple SclerosisExperimental Autoimmune EncephalomyelitisT-LymphocyteCytokineSignal TransductionCellsInflammatoryImmunoregulationLaboratoriesReceptorHla-Dr2 AntigenPeptidesChronicDesignClinical TrialsMhc Class Ii GenesAffectProgramsLigandsRisk FactorsMigration Inhibitory FactorLinkTissuesNeuroprotection
Grant awards (58)
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Preclinical Translational Studies with DRHQ$0
I01 · FY2024 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2024 · VA · contact PI
Preclinical Translational Studies with DRHQ$0
I01 · FY2023 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2023 · VA · contact PI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$996,486
R44 · FY2022 · AI
Preclinical Translational Studies with DRHQ$0
I01 · FY2022 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2022 · VA · contact PI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$996,926
R44 · FY2021 · AI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2021 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2021 · VA · contact PI
Preclinical Translational Studies with DRHQ$0
I01 · FY2021 · VA · contact PI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$998,210
R44 · FY2020 · AI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2020 · VA · contact PI
Preclinical Translational Studies with DRHQ$0
I01 · FY2020 · VA · contact PI
Immunoregulation of Myelin-Specific T Lymphocytes$0
I01 · FY2020 · VA · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2019 · VA · contact PI
Immunoregulation of Myelin-Specific T Lymphocytes$0
I01 · FY2019 · VA · contact PI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$747,347
R42 · FY2018 · AI · contact PI
BLR&D Research Career Scientist Award Application$0
IK6 · FY2018 · VA · contact PI
Immunoregulation of Myelin-Specific T Lymphocytes$0
I01 · FY2018 · VA · contact PI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$702,706
R42 · FY2017 · AI · contact PI
Immunoregulation of Myelin-Specific T Lymphocytes$0
I01 · FY2017 · VA · contact PI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$224,796
R41 · FY2016 · AI · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2016 · VA · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2015 · VA · contact PI
Regulation of EAE with Recombinant TCR Ligands$294,154
R01 · FY2014 · NS · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2014 · VA · contact PI
Regulation of EAE with Recombinant TCR Ligands$286,725
R01 · FY2013 · NS · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2013 · VA · contact PI
Regulation of EAE with Recombinant TCR Ligands$297,125
R01 · FY2012 · NS · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2012 · VA · contact PI
Regulation of EAE with Recombinant TCR Ligands$297,125
R01 · FY2011 · NS · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2011 · VA · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2011 · VA · contact PI
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$368,351
R01 · FY2010 · NS · contact PI
Regulation of EAE with Recombinant TCR Ligands$303,188
R01 · FY2010 · NS · contact PI
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$361,234
R01 · FY2009 · NS · contact PI
REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS$336,724
R01 · FY2009 · NS · contact PI
Immunoregulation of Myelin Specific T Lymphocytes$0
I01 · FY2009 · VA · contact PI
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$350,713
R01 · FY2008 · NS · contact PI
REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS$336,724
R01 · FY2008 · NS · contact PI
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$350,707
R01 · FY2007 · NS · contact PI
REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS$336,452
R01 · FY2007 · NS · contact PI
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$350,659
R01 · FY2006 · NS · contact PI
REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS$340,061
R01 · FY2006 · NS · contact PI
Development of a T cell specific multiple sclerosis drug$359,127
R42 · FY2005 · NS
REGULATION OF EAE WITH RECOMBINANT TCR LIGANDS$348,244
R01 · FY2005 · NS
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$377,500
R01 · FY2004 · NS
Development of a T cell specific multiple sclerosis drug$361,013
R42 · FY2004 · NS
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$377,500
R01 · FY2003 · NS
Development of a T cell specific multiple sclerosis drug$99,808
R41 · FY2003 · NS
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$377,500
R01 · FY2002 · NS
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$377,500
R01 · FY2001 · NS
REGULATION OF AUTOIMMUNITY WITH T CELL RECEPTOR PEPTIDES$377,500
R01 · FY2000 · NS